Identifying NTRK and RET Alterations in Differentiated Thyroid Cancer
Lova Sun, MD, discusses genetic alterations in thyroid cancer, including RET and NTRK alterations, and how these can affect treatment options.
Lova Sun, MD, discusses genetic alterations in thyroid cancer, including RET and NTRK alterations, and how these can affect treatment options.
This study of 5-year follow-up data from a phase 2 clinical trial examines the association of response with 12 induction instillations of bacillus Calmette-Guèrin (BCG)…
About 4% of US cancer survivors surveyed said they adhere to the American Cancer Society’s nutrition and physical activity guidelines.
This review assesses current evidence and emerging treatment strategies for improved survival among patients with metastatic hormone-sensitive prostate cancer and offers recommendations for clinical practice…
Ocular melanoma is very different from melanoma skin cancer. Read about this rare form of melanoma also known as uveal melanoma.
Dostarlimab plus chemotherapy has been granted priority review from the FDA to expand its indication to all adult patients with primary advanced or recurrent endometrial…
TAR-210 was safe and showed promising clinical activity in patients with FGFR-altered high- and intermediate-risk non–muscle-invasive bladder cancer.
LUNGevity offers the largest online network of support and in-person survivorship programs for all people affected by lung cancer. Through our LifeLine Program, we offer…
Sumanta Kumar Pal, MD, FASCO, presents the case of a 48-year-old man with renal cell carcinoma, and Rana R. McKay, MD, discusses how she discusses…
In this discussion, Faith Davies, MD, MRCP, MRCPath, FRCPath, NYU Langone, New York City, NY, Mala Shanmugam, MS, PhD, Emory School of Medicine, Atlanta, GA,…